Follow-up of the remaining bladder after supravesical urinary diversion.
OBJECTIVE
To review our experience in 14 patients who underwent supravesical urinary diversion maintaining their defunctionalized bladder in situ.


METHODS
A variety of pathological entities indicated surgery, including neurogenic bladder, urinary tuberculosis (with severely contracted bladder), interstitial cystitis, and retroperitoneal fibrosis.


RESULTS
Global analysis revealed a total of 11 patients (78.5%) who presented complications, the most frequent being mucopurulent and bloody secretions (28.5%), and painful bladder spasms (14.2%), followed by hemorrhage, pyocystis, hypogastric or urethral pain, and sepsis.


CONCLUSIONS
Two patients (14.2%) required hospitalization for treatment of complications. The majority of complications were treated successfully with bladder irrigations and antibiotics. One patient required total cystectomy secondary to pyocystis.
Granados
E A
EA
Chief Section of Urologic Endoscopy, Puigvert Foundation, Barcelona, Spain.
Salvador
J
J
Vicente
J
J
Villavicencio
H
H
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001437:Bacteriuria / Q000382:microbiology / Q000628:therapy; D018856:Cystitis, Interstitial / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007431:Intraoperative Complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000628:therapy; D012185:Retroperitoneal Fibrosis / Q000601:surgery; D007507:Therapeutic Irrigation; D014401:Tuberculosis, Urogenital / Q000601:surgery; D001743:Urinary Bladder / Q000473:pathology*; D001745:Urinary Bladder Diseases / Q000209:etiology* / Q000628:therapy; D001750:Urinary Bladder, Neurogenic / Q000601:surgery; D014547:Urinary Diversion / Q000009:adverse effects
D000900:Anti-Bacterial Agents